TY - JOUR
T1 - Viscosupplementation for osteoarthritis of the knee
T2 - A key opinion leader panel discussion
AU - Bert, Jack
AU - Kenney, Jim
AU - Sgaglione, Nicholas A.
AU - McClelland, Scott
AU - Brophy, Robert
AU - Toth, John
AU - Ruane, Joseph
AU - Ali, Yousaf
AU - Arquette, Sheila
AU - Dasa, Vinod
AU - Lopes, Maria
N1 - Funding Information:
This panel discussion and report was facilitated by Magellan Rx Management and funded by Sanofi.
Publisher Copyright:
Copyright © 2018, Academy of Managed Care Pharmacy. All rights reserved.
PY - 2018/6
Y1 - 2018/6
N2 - With a sharp rise in the prevalence of osteoarthritis of the knee (OAK) in a younger population, new management strategies are needed to preserve mobility, improve patients' quality of life, and reduce the effects of potential disease-related comorbidities. Viscosupplementation with the use of hyaluronic acid (HA) injection is a treatment option for OAK that can provide lubrication and elastic shock absorption, leading to potential pain relief, improved function, and reduced stiffness. A key opinion leader (KOL) panel discussion was held December 3, 2016, with the objective of sharing opinions, ideas, information, and trends regarding OAK and the potential treatment and management offered by viscosupplementation. The panel concluded that viscosupplementation with HA injections presents a viable, cost-effective, and safe alternative for the treatment of OAK.
AB - With a sharp rise in the prevalence of osteoarthritis of the knee (OAK) in a younger population, new management strategies are needed to preserve mobility, improve patients' quality of life, and reduce the effects of potential disease-related comorbidities. Viscosupplementation with the use of hyaluronic acid (HA) injection is a treatment option for OAK that can provide lubrication and elastic shock absorption, leading to potential pain relief, improved function, and reduced stiffness. A key opinion leader (KOL) panel discussion was held December 3, 2016, with the objective of sharing opinions, ideas, information, and trends regarding OAK and the potential treatment and management offered by viscosupplementation. The panel concluded that viscosupplementation with HA injections presents a viable, cost-effective, and safe alternative for the treatment of OAK.
UR - http://www.scopus.com/inward/record.url?scp=85054088600&partnerID=8YFLogxK
U2 - 10.18553/JMCP.2018.24.6-A.S2
DO - 10.18553/JMCP.2018.24.6-A.S2
M3 - Article
C2 - 29851537
AN - SCOPUS:85054088600
SN - 2376-0540
VL - 24
SP - S2-S7
JO - Journal of managed care & specialty pharmacy
JF - Journal of managed care & specialty pharmacy
IS - 6
ER -